Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Start-ups

Isospec Analytics raises funds for molecule identification

by Michael McCoy
April 28, 2024 | A version of this story appeared in Volume 102, Issue 13

 

Three people dressed in casual clothes.
Credit: Isopec Analytics
Isospec Analytics' founders, from left: Thomas Rizzo, Ahmed Ben Faleh, and Stephan Warnke

Isospec Analytics has raised $1.9 million in preseed funding to develop technology for rapidly identifying unknown molecules. Isospec was founded in 2022 to commercialize a technique originating from the Laboratory of Molecular Physical Chemistry at the Swiss Federal Institute of Technology, Lausanne (EPFL). The firm says its technology is already being used to analyze sugars and metabolites but that its real potential is in the discovery of new biomarkers for drugs and diagnostics.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.